Application Sponsors
Marketing Status
None (Tentative Approval) | 001 |
None (Tentative Approval) | 002 |
None (Tentative Approval) | 003 |
Application Products
001 | TABLET, EXTENDED RELEASE;ORAL | 500MG; EQ 50MG BASE | 0 | METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATE | METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE |
002 | TABLET, EXTENDED RELEASE;ORAL | 1GM; EQ 50MG BASE | 0 | METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATE | METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE |
003 | TABLET, EXTENDED RELEASE;ORAL | 1GM; EQ 100MG BASE | 0 | METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATE | METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE |
FDA Submissions
UNKNOWN; | ORIG | 1 | TA | 2015-04-21 | |
Submissions Property Types
CDER Filings
ANCHEN PHARMS
cder:Array
(
[0] => Array
(
[ApplNo] => 204144
[companyName] => ANCHEN PHARMS
[docInserts] => ["",""]
[products] => [{"drugName":"METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATE","activeIngredients":"METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE","strength":"500MG; EQ 50MG BASE","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATE","activeIngredients":"METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE","strength":"1GM; EQ 50MG BASE","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATE","activeIngredients":"METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE","strength":"1GM; EQ 100MG BASE","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"04\/21\/2015","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2015-04-21
)
)